SENTARA NORTHERN VIRGINIA MED CTR — History
CCN 490113 | 3-year financial timeline | COVID resilience: 44/100
🛡️ Public data only — no PHI permitted on this instance.
$286M
Latest Revenue (FY2022)
+8.2%
Revenue CAGR (3yr)
-4.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $245M | $276M | $286M | +3.8% | +8.2% |
| Operating Expenses | $217M | $269M | $299M | +10.9% | +17.2% |
| Operating Margin | 11.2% | 2.4% | -4.3% | -282.2% | +0.0% |
| Net Income | $27M | $7M | $-12M | -289.2% | +0.0% |
| Licensed Beds | 147 | 147 | 147 | +0.0% | +0.0% |
| Total Patient Days | 48,730 | 50,483 | 51,164 | +1.3% | +2.5% |
| Medicare Day % | 34% | 30% | 30% | +1.5% | -5.5% |
| Medicaid Day % | 6% | 6% | 6% | -1.8% | -0.5% |
COVID Impact & Recovery
Resilience Score: 44/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +17.0% ($245M → $286M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+8.2%
This Hospital
+7.6%
State Avg
Latest Margin
-4.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $307M | -12.0% |
| FY2024 (proj) | $328M | -19.8% |
| FY2025 (proj) | $349M | -27.5% |